Gilead Sciences

The Numbers Backing Gilead's Best and Fastest Drug Launch in History
TheStreet.com
Mon, 12/9/13 - 08:48 am
Gilead Sciences
drug launches
Sovaldi
hepatitis C
New Leukemia Drugs Bring Chemotherapy-Free Treatment Potential
Bloomberg
Mon, 12/9/13 - 08:38 am
Gilead Sciences
Roche
Pharmacyclics
CLL
chronic lymphocytic leukemia
Gilead Announces Interim Phase 2 Results for GS-9973 in Previously Treated Chronic Lymphocytic Leukemia
Yahoo/BusinessWire
Sun, 12/8/13 - 12:03 pm
chronic lymphocytic leukemia
GS-9973
Gilead Sciences
What Everybody Ought to Know About Gilead and Johnson & Johnson's New Hepatitis C Drugs
Seeking Alpha
Fri, 12/6/13 - 10:30 am
JNJ
Gilead Sciences
hepatitis C
sofosbuvir
Olysio
AbbVie
Bristol-Myers Squibb
Merck
3 Can't-Miss FDA Actions Coming in December
Motley Fool
Tue, 11/26/13 - 04:42 pm
FDA
Gilead Sciences
sofosbuvir
Forxiga
AstraZeneca
Bristol-Myers Squibb
GSK
Anoro Ellipta
Theravance
New Hepatitis C Drug Success Should Drive Gilead Sciences In 2014
Seeking Alpha
Tue, 11/26/13 - 04:37 pm
hepatitis C
Gilead Sciences
sofosbuvir
Gilead And AbbVie Battle For Top Spot In $20 Billion Hepatitis Drug Market
Seeking Alpha
Sun, 11/24/13 - 12:24 pm
Gilead Sciences
AbbVie
hepatitis
hepatitis C
sofosbuvir
ABT-450
ABT-333
ABT-267
Gilead's HIV-1 Drug Wins Approval in Europe
Motley Fool
Tue, 11/19/13 - 07:37 am
HIV-1
Gilead Sciences
Vitekta
Europe
Don't Crown the Hepatitis C Drug Winner Just Yet
Motley Fool
Tue, 11/19/13 - 07:35 am
hepatitis C
Gilead Sciences
ABT-333
Ribavirin
ABT-450
ritonavir
ABT-267
AbbVie
Gilead Five-year Revenue Outlook, Part 1
Seeking Alpha
Tue, 11/12/13 - 01:10 pm
Gilead Sciences
How Much? A Battle Over The Cost Of The New Hepatitis C Drugs
Pharmalot
Mon, 11/11/13 - 11:40 am
hepatitis C
drug pricing
sofosbuvir
FDA
Gilead Sciences
Gilead Sciences and Johnson & Johnson Push Vertex Out of Hepatitis C Race
Motley Fool
Sun, 11/3/13 - 12:06 pm
Gilead Sciences
JNJ
Vertex Pharmaceuticals
hepatitis
hepatitis B
This Week in Biotech: Twitter Edition
Motley Fool
Sat, 11/2/13 - 11:36 am
Gilead Sciences
PDL Biopharma
Depomed
Vertex Pharmaceuticals
JNJ
Sarepta Therapeutics
The Surprising Company Taking On America's Most Fatal Disease
Motley Fool
Fri, 11/1/13 - 11:46 am
Ranexa
Gilead Sciences
angina
cardiovascular disease
Gilead Sciences' CEO Discusses Q3 2013 Results - Earnings Call Transcript
Yahoo/Seeking Alpha
Wed, 10/30/13 - 09:46 am
Gilead Sciences
earnings
This Week in Biotech
Motley Fool
Sun, 10/27/13 - 12:48 pm
Immunomedics
Zogenix
Gilead Sciences
Osiris Therapeutics
Repros Therapeutics
Gilead Stops Leukemia Drug Trial Early on Patient Benefit
Bloomberg
Thu, 10/10/13 - 08:13 am
Gilead Sciences
Idelalisib
Rituxan
chronic lymphocytic leukemia
Top Biotechs Set to Win in the War on Cancer
Yahoo/Wall St 24-7
Thu, 10/3/13 - 11:57 am
biotech
Biomarin
Immunogen
Ariad Pharmaceuticals
Amgen
Celgene
Gilead Sciences
Insiders Are Selling Gilead Sciences
Seeking Alpha
Sun, 09/29/13 - 01:29 pm
Gilead Sciences
3 Companies That Could Make You a Successful Clinical-Stage Biotech Investor
Motley Fool
Sun, 09/29/13 - 01:23 pm
Gilead Sciences
Isis Pharmaceuticals
Nektar

Pages